您当前的位置：
首页 >
文章列表页 >
CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer
Editorial | 更新时间：2024-02-04

    • CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer

    • Genes & Diseases   Vol. 11, Issue 3, (2024)
    • 作者机构：

      Department of Oncology, Zhujiang Hospital, Southern Medical University,Guangdong,Guangzhou,China,510282

    • DOI：10.1016/j.gendis.2023.06.011    

      CLC：

    • Published：2024，

      Published Online：1 May 2024，

    扫 描 看 全 文

  • Anqi Lin, Hong Yang, Jian Zhang, et al. CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer. [J]. Genes & Diseases 11(3).(2024) DOI： 10.1016/j.gendis.2023.06.011.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0